Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01581164 · ClinicalTrials.gov registry record
Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell Transplantation
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 12
- Enrollment target
NCT01581164 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 12 participants.
The verdict
NCT01581164 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of this research study is to perform a serial analysis of immune function using blood cells and sera obtained from patients after vaccination following hematopoietic stem cell transplantation (HSCT). The focus of this study will be to characterize several immune parameters during the clinical course of HSCT and correlate these findings with the effect of vaccination.
Interventions
- BIOLOGICAL Influenza vaccine
- BIOLOGICAL Varicella vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01581164
The ClinicalTrials.gov registry entry for NCT01581164 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Influenza vaccine is the first listed.
NCT01581164 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01581164 about?
NCT01581164 is a clinical study titled "Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell Transplantation". The purpose of this research study is to perform a serial analysis of immune function using blood cells and sera obtained from patients after vaccination following hematopoietic stem cell transplantation (HSCT). The focus of this study will be to characterize several immune parameters during the cli...
What is the current status of trial NCT01581164?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2011-12. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01581164?
The interventions under investigation include: Influenza vaccine (BIOLOGICAL), Varicella vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01581164?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.